We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+7.49%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$9.72B
AUM Growth
+$589M
Cap. Flow
-$37.2M
Cap. Flow %
-0.38%
Top 10 Hldgs %
31.39%
Holding
419
New
23
Increased
181
Reduced
152
Closed
9

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$48.3M
2
ABBV icon
AbbVie
ABBV
+$40.8M
3
SRE icon
Sempra
SRE
+$23.4M
4
CVX icon
Chevron
CVX
+$21.9M
5
HPQ icon
HP
HPQ
+$21.2M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$72M
2
ENB icon
Enbridge
ENB
+$61.3M
3
MSFT icon
Microsoft
MSFT
+$45.4M
4
KMB icon
Kimberly-Clark
KMB
+$42.1M
5
VIRT icon
Virtu Financial
VIRT
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 17.92%
2 Healthcare 16.37%
3 Financials 13.94%
4 Industrials 11.5%
5 Consumer Staples 11.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IYW icon
101
iShares US Technology ETF
IYW
$23.6B
$7.34M 0.08%
180,424
-5,596
-3% -$224K
UNP icon
102
Union Pacific
UNP
$174B
$7M 0.07%
52,233
-1,010
-2% -$122K
EOG icon
103
EOG Resources
EOG
$79.2B
$6.99M 0.07%
64,783
-275
-0.4% -$27.7K
LOW icon
104
Lowe's Companies
LOW
$117B
$6.9M 0.07%
74,204
+5
+0% +$413
MPWR icon
105
Monolithic Power Systems
MPWR
$70.1B
$6.87M 0.07%
61,143
+480
+0.8% +$55.7K
GLOG
106
DELISTED
GASLOG LTD
GLOG
$6.86M 0.07%
308,250
+58,456
+23% +$1.08M
HUBB icon
107
Hubbell
HUBB
$25B
$6.85M 0.07%
50,617
+8,832
+21% +$1.1M
GE icon
108
GE Aerospace
GE
$374B
$6.82M 0.07%
81,550
-40,216
-33% -$3.84M
CMD
109
DELISTED
Cantel Medical Corporation
CMD
$6.17M 0.06%
59,984
+1,735
+3% +$173K
WPC icon
110
W.P. Carey
WPC
$16.8B
$6.06M 0.06%
89,813
+4,856
+6% +$332K
DCI icon
111
Donaldson
DCI
$10.9B
$5.97M 0.06%
121,978
-15,790
-11% -$753K
SIMO icon
112
Silicon Motion
SIMO
$8.6B
$5.86M 0.06%
110,602
+23,979
+28% +$1.21M
BMY icon
113
Bristol-Myers Squibb
BMY
$133B
$5.76M 0.06%
93,993
+3,648
+4% +$228K
TXRH icon
114
Texas Roadhouse
TXRH
$13.5B
$5.42M 0.06%
102,863
+775
+0.8% +$39.2K
HMN icon
115
Horace Mann Educators
HMN
$2.1B
$5.36M 0.06%
121,600
+12,182
+11% +$531K
BRK.A icon
116
Berkshire Hathaway Class A
BRK.A
$1.1T
$5.36M 0.06%
18
MSFG
117
DELISTED
MainSource Financial Group Inc
MSFG
$5.2M 0.05%
143,093
+16,501
+13% +$618K
FITB
118
Fifth Third Bancorp
FITB
$51.2B
$5.19M 0.05%
171,000
-9,727
-5% -$284K
GPC icon
119
Genuine Parts
GPC
$17.1B
$5.14M 0.05%
54,115
-66,800
-55% -$6.1M
JKHY icon
120
Jack Henry & Associates
JKHY
$10.9B
$5.06M 0.05%
43,300
T icon
121
AT&T
T
$159B
$4.97M 0.05%
169,361
-11,873
-7% -$324K
AVNT icon
122
Avient
AVNT
$3.33B
$4.86M 0.05%
111,710
+5,995
+6% +$263K
LCII icon
123
LCI Industries
LCII
$2.49B
$4.82M 0.05%
37,079
+12,916
+53% +$1.59M
XLK icon
124
State Street Technology Select Sector SPDR ETF
XLK
$115B
$4.8M 0.05%
150,274
-4,750
-3% -$149K
VZ icon
125
Verizon
VZ
$195B
$4.79M 0.05%
90,415
-3,491
-4% -$172K

Similar funds

Bahl & Gaynor's Q4 2017 Portfolio in Review

As of Q4 2017, Bahl & Gaynor held 419 positions worth $9.72B, up 6.4% from $9.13B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Bahl & Gaynor's Q4 2017 filing shows 23 new, 181 increased, 152 reduced and 9 closed positions. Its largest new stake was iShares Core High Dividend ETF: 534,010 shares worth $9.63M. The largest sale was Merck, an estimated $72M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

  • Bahl & Gaynor's largest Q4 2017 buy was iShares Core High Dividend ETF: 534,010 shares worth $9.63M.
  • Bahl & Gaynor added most to Amgen in Q4 2017, an estimated $48.3M increase.
  • Bahl & Gaynor's biggest Q4 2017 reduction was Merck, cutting an estimated $72M.
  • Bahl & Gaynor fully exited Virtu Financial in Q4 2017, selling an estimated $10.4M.
  • Bahl & Gaynor's ten largest holdings make up 31% of its $9.72B portfolio in Q4 2017.
  • Bahl & Gaynor opened 23 new positions and closed 9 in Q4 2017.
  • Bahl & Gaynor's portfolio value rose 6.4% quarter-over-quarter to $9.72B.

Based on Bahl & Gaynor's 13F filing for Q4 2017, filed 13 Feb 2018.